Dr. Kalyanam Shivkumar, MD, PhD, FACC, FHRS Has Joined the Board of Directors at BioSig Technologies, Inc.
LOS ANGELES, March 26, 2013 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (BioSig), a medical device company developing unique clinical solutions for the electrophysiology market, announced that Dr. Kalyanam Shivkumar, MD, PhD, FACC, FHRS has joined the Company's Board of Directors.
Dr. Shivkumar is currently Professor of Medicine and Radiology at UCLA and leads the UCLA Cardiac Arrhythmia Center. Dr. Shivkumar brings to BioSig a special combination of skills as a clinician, teacher, researcher, and innovator in the field of electrophysiology and cardiovascular therapies.
Kenneth L. Londoner, Chairman and Chief Executive Officer of BioSig Technologies, Inc. commented, "It is a real privilege to work with Dr. Shivkumar and he is a great addition to BioSig's Board of Directors. His talents, combined with the other leadership of BioSig's fully independent Board, will guide our clinical validation and, ultimately, commercialization. We look forward to collaborating with Dr. Shivkumar to make a significant contribution to the field of electrophysiology."
Dr. Shivkumar stated, "BioSig's Technology team has a very unique approach in solving challenging issues faced in everyday electrophysiology practice with the ultimate goal of greatly improving outcomes for arrhythmia patients treated by cardiac catheter ablation. I plan to work closely with the rest of BioSig's Medical Advisory Board to provide a clinical perspective."
About BioSig Technologies, Inc.
BioSig Technologies, Inc. is a medical device company developing unique clinical solutions for the diagnosis and treatment of arrhythmias. BioSig's PURE EP (Precise Uninterrupted Real-time evaluations of Electrograms) platform is designed to assist electrophysiologists during the termination of arrhythmias by catheter ablation. PURE EP empowers electrophysiologists to make crucial clinical decisions in real-time by providing information unobtainable with any other equipment presently in the electrophysiology (EP) lab.
The BioSig Technologies, Inc. logo is available at https://www.globenewswire.com/newsroom/prs/?pkgid=14637
CONTACT: Lora Mikolaitis Director of Operations BioSig Technologies, Inc. 12424 Wilshire Blvd Suite 745 Los Angeles, CA 90025 email@example.com
Released March 26, 2013